Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix® System
a study on Aneurysm
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San diego, California and other locations
- Dates
- study startedestimated completion
Description
Summary
The objective of this study is to assess the safety and effectiveness of the Endologix Nellix® System for the endovascular repair of infrarenal abdominal aortic aneurysms (AAA).
Official Title
Prospective, Multicenter, Single Arm Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix® System: A Pivotal and Continued Access Study
Details
This study will evaluate the safety and effectiveness of the Nellix System among a wide range of physicians and in consecutively enrolled subjects to assess outcomes generalizability. Following appropriate government and ethics committee/IRB approval the Nellix® EndoVascular Sealing System will be implanted into eligible patients who are adequately informed and have consented to join the study. Enrolled patients will undergo a high resolution, contrast-enhanced computed tomography angiography (CT) scan of the relevant aortic and aortoiliac vasculature within three months of the scheduled procedure and at specified follow-up intervals post-implantation. Follow-up visits will occur at 30 days, 6 months, and annually to 5 years to assess aneurysm morphology, the status of the implanted devices, and relevant laboratory test results.
Keywords
Abdominal Aortic Aneurysm (AAA) Infrarenal Abdominal Aortic Aneurysm AAA Endologix EVAS EndoVascular Sealing System Aortic Aneurysm Aortic Aneurysm, Abdominal Nellix System
Eligibility
You can join if…
Open to people ages 18 years and up
- Male or female at least 18 years old;
- Informed consent understood and signed;
- Patient agrees to all follow-up visits;
- Have AAA with sac diameter ≥5.0cm, or ≥4.5 cm which has increased by >1.0cm in the past year.
- Anatomic eligibility for the Nellix System per the instructions for use:
- Adequate iliac/femoral access compatible with the required delivery systems (diameter ≥6 mm);
- Aneurysm blood lumen diameter ≤60mm;
- Most caudal renal artery to aortoiliac bifurcation length ≥100mm;
- Proximal non-aneurysmal aortic neck: length ≥10mm; lumen diameter 18 to 32mm; angle ≤60° to the aneurysm sac;
- Common iliac artery lumen diameter between 9 and 35mm with blood lumen diameter ≤35mm;
- Ability to preserve at least one hypogastric artery.
You CAN'T join if...
- Life expectancy <2 years;
- Psychiatric or other condition that may interfere with the study;
- Participating in enrollment of another clinical study
- Known allergy to device any device component;
- Coagulopathy or uncontrolled bleeding disorder;
- Ruptured, leaking or mycotic aneurysm;
- Serum creatinine level >2.0mg/dL;
- CVA or MI within three months of enrollment/treatment;
- Aneurysmal disease of the descending thoracic aorta;
- Clinically significant infrarenal mural thrombus (>5mm thickness over >50% circumference);
- Connective tissue diseases (e.g., Marfan Syndrome)
- Unsuitable vascular anatomy;
- Pregnant (females of childbearing potential only).
Locations
- VA San Diego
accepting new patients
San diego California 92161 United States - Tucson Medical Center
accepting new patients
Tucson Arizona 85712 United States
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Endologix
- ID
- NCT01726257
- Study Type
- Interventional
- Last Updated
Please contact me about this study
We will not share your information with anyone other than the team in charge of this study. Submitting your contact information does not obligate you to participate in research.
Thank you!
The study team should get back to you in a few business days.